The Clorox Company (CLX), headquartered in Oakland, California, manufactures and sells consumer and professional products. Valued at $19.6 billion by market cap, the company offers a range of products, including home care cleaning and disinfecting products, trash bags, food, personal care, and vitamins, under brands like Clorox, Brita, Burt's Bees, and Hidden Valley. The consumer products giant is expected to announce its fiscal second-quarter earnings for 2025 after the market closes on Monday, Feb. 3.
Ahead of the event, analysts expect CLX to report a profit of $1.39 per share on a diluted basis, down 35.7% from $2.16 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.
For the full year, analysts expect CLX to report EPS of $6.87, up 11.4% from $6.17 in fiscal 2024. Its EPS is expected to rise 4.7% year over year to $7.19 in fiscal 2026.
CLX stock has underperformed the S&P 500’s ($SPX) 24.4% gains over the past 52 weeks, with shares up 10.5% during this period. However, it outperformed the Consumer Staples Select Sector SPDR Fund’s (XLP) 4.7% gains over the same time frame.
Clorox struggles from the overestimated post-pandemic demand and ballooning inflation has led to its underperformance.
On Oct. 30, CLX shares closed down marginally after reporting its Q1 results. Its revenue was $1.8 billion, falling short of Wall Street forecasts of $1.6 billion. The company’s adjusted EPS of $1.86, surpassed analyst estimates of $1.36. CLX expects full-year adjusted EPS to be between $6.65 and $6.90.
Analysts’ consensus opinion on CLX stock is cautious, with a “Hold” rating overall. Out of 20 analysts covering the stock, one advises a “Strong Buy” rating, 15 give a “Hold,” and four recommend a “Strong Sell.” CLX’s average analyst price target is $161.28, indicating a potential upside of 1.9% from the current levels.
